Truist lowered the firm’s price target on Intuitive Surgical (ISRG) to $525 from $600 and keeps a Buy rating on the shares as part of a broader ...
Alongside reporting results of its financial year that completed at the end of March, healthcare and pharmaceutical products distributor McKesson announced plans to separate its Medical-Surgical ...
The shopping cart in front of you holds a ceramic soup tureen, three Hawaiian shirts, a stack of mystery novels, and what might be either exercise equipment or modern art – and somehow this makes ...
Intuitive Surgical is looking at a vast long-term opportunity in its market. The company's moat practically guarantees it will remain a leader in the field. This strong position in its industry can ...
Intuitive Surgical's stock has been in a free fall since the company reported earnings a few months ago. Investors appear to be worried about the impact that tariffs will have on both its top and ...
Intuitive Surgical (ISRG) just made waves by unveiling a suite of new software features for its da Vinci 5 robotic surgical system, signaling a fresh push to keep its platform on the cutting edge.
Intuitive Surgical's robots help surgeons perform millions of procedures annually. Outfitting a room for a da Vinci machine and training surgeons to use it is an expense hospitals generally want to ...
Median wait times for several key diagnostic tests and surgeries are once again increasing in Manitoba — some at or surpassing pandemic levels — nearly two years after the NDP swept to power on a ...
On Friday, Intuitive Surgical Inc. (NASDAQ:ISRG) unveiled the first set of new software capabilities for its da Vinci 5 surgical system, which is aimed at boosting surgeon performance and hospital ...
SANTIAGO, Sept 10 (Reuters) - Ricardo Funke, the chief of surgery at Clinica Las Condes in Santiago, Chile, had a new assistant during a laparoscopic surgery on Monday - an autonomous artificial ...
SHANGHAI--(BUSINESS WIRE)--Ronovo Surgical, a global innovator in next-generation surgical robotics, announced today the successful closing of its Series D financing, led by Johnson & Johnson’s ...
Despite the stock's downward trend lately, the company is growing at an impressive pace. Management recently warned investors about some of the key risks and pressures the robotics company faces.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results